Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
Clinical trial NCT00430586 · COMPLETED
Trial details
- NCT number
- NCT00430586
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.